Table 2. Univariate and multivariate analyses for cancer-specific survival.
Univariate analysis | Multivariate analysis | |||||||||
CI 95% | CI 95% | |||||||||
Variable | Category | HR | Lower | Higher | p value | HR | Lower | Higher | p value | |
T stage | T3-4 vs T1-2 | 2.09 | 1.59 | 2.75 | 0.0001 | 1.56 | 1.14 | 2.13 | 0.004 | |
N stage | N+ vs N0 | 3.49 | 1.84 | 6.60 | 0.001 | 1.25 | 1.01 | 2.68 | 0.02 | |
M stage | M+ vs M0 | 6.15 | 3.44 | 10.97 | 0.0001 | 4.77 | 2.05 | 9.12 | 0.003 | |
Grade | G3-4 vs G1-2 | 2.24 | 1.15 | 6.86 | 0.01 | 1.41 | 1.05 | 2.08 | 0.02 | |
Necrosis | Yes vs No | 2.06 | 1.18 | 3.86 | 0.01 | - | - | - | - | |
Tumor size | Continuous | 1.48 | 1.12 | 2.26 | 0.01 | - | - | - | - | |
PTX3 | >165.0 vs <165.0 pg/ml | 2.41 | 1.21 | 6.31 | 0.001 | 1.86 | 1.05 | 2.86 | 0.01 |
CI: confidence interval; HR: hazard ratio.